BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roma MI, Hocht C, Chiappetta DA, Di Gennaro SS, Minoia JM, Bramuglia GF, Rubio MC, Sosnik A, Peroni RN. Tetronic® 904-containing polymeric micelles overcome the overexpression of ABCG2 in the blood-brain barrier of rats and boost the penetration of the antiretroviral efavirenz into the CNS. Nanomedicine (Lond) 2015;10:2325-37. [PMID: 26252052 DOI: 10.2217/NNM.15.77] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Toscanini MA, Limeres MJ, Garrido AV, Cagel M, Bernabeu E, Moretton MA, Chiappetta DA, Cuestas ML. Polymeric micelles and nanomedicines: Shaping the future of next generation therapeutic strategies for infectious diseases. Journal of Drug Delivery Science and Technology 2021;66:102927. [DOI: 10.1016/j.jddst.2021.102927] [Reference Citation Analysis]
2 Kostevšek N, Hudoklin S, Kreft ME, Serša I, Sepe A, Jagličić Z, Vidmar J, Ščančar J, Šturm S, Kobe S, Žužek Rožman K. Magnetic interactions and in vitro study of biocompatible hydrocaffeic acid-stabilized Fe–Pt clusters as MRI contrast agents. RSC Adv 2018;8:14694-704. [DOI: 10.1039/c8ra00047f] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
3 Almeida M, Magalhães M, Veiga F, Figueiras A. Poloxamers, poloxamines and polymeric micelles: Definition, structure and therapeutic applications in cancer. J Polym Res 2018;25. [DOI: 10.1007/s10965-017-1426-x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
4 Minoia JM, Filia MF, Roma MI, De Fino FT, Copello GJ, Peroni RN. Selective modulation of placental and fetal MDR transporters by chronic in utero exposure to NRTIs in Sprague-Dawley rats: Importance for fetoprotection. Toxicol Appl Pharmacol 2022;450:116170. [PMID: 35843342 DOI: 10.1016/j.taap.2022.116170] [Reference Citation Analysis]
5 Egner TK, Naik P, Nelson NC, Slowing II, Venditti V. Mechanistic Insight into Nanoparticle Surface Adsorption by Solution NMR Spectroscopy in an Aqueous Gel. Angew Chem Int Ed Engl 2017;56:9802-6. [PMID: 28640513 DOI: 10.1002/anie.201704471] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
6 Filia MF, Marchini T, Minoia JM, Roma MI, De Fino FT, Rubio MC, Copello GJ, Evelson PA, Peroni RN. Induction of ABCG2/BCRP restricts the distribution of zidovudine to the fetal brain in rats. Toxicol Appl Pharmacol 2017;330:74-83. [PMID: 28705594 DOI: 10.1016/j.taap.2017.07.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Ling G, Zhang T, Zhang P, Sun J, He Z. Nanostructured lipid-carrageenan hybrid carriers (NLCCs) for controlled delivery of mitoxantrone hydrochloride to enhance anticancer activity bypassing the BCRP-mediated efflux. Drug Dev Ind Pharm 2016;42:1351-9. [PMID: 26754913 DOI: 10.3109/03639045.2015.1135937] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
8 Mcnamara K, Tofail SAM. Nanoparticles in biomedical applications. Advances in Physics: X 2016;2:54-88. [DOI: 10.1080/23746149.2016.1254570] [Cited by in Crossref: 74] [Cited by in F6Publishing: 15] [Article Influence: 12.3] [Reference Citation Analysis]
9 Awad R, Avital A, Sosnik A. Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.07.003] [Reference Citation Analysis]
10 Kevadiya BD, Ottemann BM, Thomas MB, Mukadam I, Nigam S, McMillan J, Gorantla S, Bronich TK, Edagwa B, Gendelman HE. Neurotheranostics as personalized medicines. Adv Drug Deliv Rev 2019;148:252-89. [PMID: 30421721 DOI: 10.1016/j.addr.2018.10.011] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 11.7] [Reference Citation Analysis]
11 Lasemi N, Bomatí miguel O, Lahoz R, Lennikov VV, Pacher U, Rentenberger C, Kautek W. Laser‐Assisted Synthesis of Colloidal FeW x O y and Fe/Fe x O y Nanoparticles in Water and Ethanol. ChemPhysChem 2018;19:1414-9. [DOI: 10.1002/cphc.201701214] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
12 Egner TK, Naik P, Nelson NC, Slowing II, Venditti V. Mechanistic Insight into Nanoparticle Surface Adsorption by Solution NMR Spectroscopy in an Aqueous Gel. Angew Chem 2017;129:9934-8. [DOI: 10.1002/ange.201704471] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
13 Hu Z, Wei Q, Zhang H, Tang W, Kou Y, Sun Y, Dai Z, Zheng X. Advances in FePt-involved nano-system design and application for bioeffect and biosafety. J Mater Chem B 2021. [PMID: 34951441 DOI: 10.1039/d1tb02221k] [Reference Citation Analysis]
14 Bonvento M, Button T, Srivastava P. CT contrast agent evaluation model. Biomed Phys Eng Express 2018;4:067005. [DOI: 10.1088/2057-1976/aad545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Zheng X, Wang Y, Sun L, Chen N, Li L, Shi S, Malaisamy S, Yan C. TbF3 nanoparticles as dual-mode contrast agents for ultrahigh field magnetic resonance imaging and X-ray computed tomography. Nano Res 2016;9:1135-47. [DOI: 10.1007/s12274-016-1008-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
16 Tsai Y, Tang C, Wu H, Wang Y, Chen Y. Antibacterial Activity of Cysteine-Derived Cationic Dipeptides. Int J Pept Res Ther 2020;26:1107-14. [DOI: 10.1007/s10989-019-09913-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
17 McNamara K, Tofail SA. Nanosystems: the use of nanoalloys, metallic, bimetallic, and magnetic nanoparticles in biomedical applications. Phys Chem Chem Phys 2015;17:27981-95. [PMID: 26024211 DOI: 10.1039/c5cp00831j] [Cited by in Crossref: 111] [Cited by in F6Publishing: 20] [Article Influence: 15.9] [Reference Citation Analysis]
18 Rani R, Sethi K, Singh G. Nanomaterials and Their Applications in Bioimaging. In: Prasad R, editor. Plant Nanobionics. Cham: Springer International Publishing; 2019. pp. 429-50. [DOI: 10.1007/978-3-030-16379-2_15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
19 Sosnik A, Augustine R. Challenges in oral drug delivery of antiretrovirals and the innovative strategies to overcome them. Adv Drug Deliv Rev 2016;103:105-20. [PMID: 26772138 DOI: 10.1016/j.addr.2015.12.022] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 9.8] [Reference Citation Analysis]
20 Qian Z, Hu W, Pan Y. Biofunctional Magnetic Nanomaterials for Diagnosis, Therapy, and Theranostic Applications. Theranostic Bionanomaterials. Elsevier; 2019. pp. 341-56. [DOI: 10.1016/b978-0-12-815341-3.00015-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Kostevšek N, Šturm S, Serša I, Sepe A, Bloemen M, Verbiest T, Kobe S, Žužek Rožman K. “Single-” and “multi-core” FePt nanoparticles: from controlled synthesis via zwitterionic and silica bio-functionalization to MRI applications. J Nanopart Res 2015;17. [DOI: 10.1007/s11051-015-3278-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
22 Wang J, Yue L, Hu Z, Dai Z, Qi Y, Zheng X, Li Z, Yu D. Multifunctional FePt–Au heterodimers: promising nanotheranostic agents for dual-modality MR/CT imaging diagnosis and in situ cancer therapy. RSC Adv 2016;6:107331-6. [DOI: 10.1039/c6ra23645f] [Cited by in Crossref: 14] [Article Influence: 2.3] [Reference Citation Analysis]
23 Aggarwal N, Sachin, Nabi B, Aggarwal S, Baboota S, Ali J. Nano-based drug delivery system: a smart alternative towards eradication of viral sanctuaries in management of NeuroAIDS. Drug Deliv Transl Res 2021. [PMID: 33486689 DOI: 10.1007/s13346-021-00907-8] [Reference Citation Analysis]
24 Li Y, Meng L, Hu Y, Zhang T, Su Z, Ouyang Z, Li W, Wan J, Wu Q. Suppression mechanisms on proliferation of glioma U251 cells by FePt nanoparticles through intracellular oxidative stress. Rare Met . [DOI: 10.1007/s12598-021-01885-z] [Reference Citation Analysis]
25 Pawar AA, Sahoo J, Verma A, Lodh A, Lakkakula J. Usage of Platinum Nanoparticles for Anticancer Therapy over Last Decade: A Review. Part Part Syst Charact 2021;38:2100115. [DOI: 10.1002/ppsc.202100115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]